Institution
Roussel Uclaf
About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid
Papers published on a yearly basis
Papers
More filters
•
04 Jan 1994TL;DR: In this article, a novel process for the preparation of a compound of the formula "STR1" was proposed, where R 1, R 2, R 3 and R 4 are defined in the text.
Abstract: A novel process for the preparation of a compound of the formula ##STR1## wherein R 1 , R 2 , R 3 and R 4 are defined in the text.
8 citations
•
14 Nov 1994TL;DR: In this paper, a method of treating hyperandrogenism in warm-blooded animals comprising administering to warmblooded animals an antiandro genically effective amount of oenotheine B and a process for the preparation of OENOTE B was described.
Abstract: A method of treating hyperandrogenism in warm-blooded animals comprising administering to warm-blooded animals an antiandro genically effective amount of oenotheine B and a process for the preparation of oenotheine B
8 citations
•
19 Aug 1988TL;DR: In this paper, the invention relates to compounds of formula (I): wherein R is either hydrogen or linear, branched or cyclic, saturated or unsaturated wherein R wherein R
Abstract: The invention relates to compounds of formula (I): wherein R is either hydrogen or linear, branched or cyclic, saturated or unsaturated wherein R wherein R
8 citations
•
07 Mar 1994TL;DR: A compound in all racemic or optionally active forms selected from the group consisting of a compound of the formula STR1## where the substituents are defined as in the specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-anoxic activity and a novel process and intermediates for their preparation.
Abstract: A compound in all racemic or optionally active forms selected from the group consisting of a compound of the formula ##STR1## where the substituents are defined as in the specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-anoxic activity and a novel process and intermediates for their preparation.
8 citations
••
TL;DR: VPA and all teratogenic analogues, at 3 mM, inhibited neuronal cell aggregation and limb bud chondrocyte differentiation in a manner that exhibited a reasonable correlation with their in vivo teratogenicity.
8 citations
Authors
Showing all 1888 results
Name | H-index | Papers | Citations |
---|---|---|---|
Fernand Labrie | 110 | 885 | 48308 |
Lionel H. Opie | 84 | 519 | 25964 |
Alain Bélanger | 70 | 244 | 16469 |
Michel J. Tremblay | 53 | 273 | 10485 |
Pierre Monsan | 51 | 216 | 8049 |
Samir Z. Zard | 50 | 575 | 10739 |
Alejandro Aruffo | 47 | 123 | 14084 |
Samuel S.C. Yen | 47 | 96 | 6865 |
Dominique Maraninchi | 47 | 188 | 8108 |
Serge Erlinger | 46 | 152 | 8200 |
Romain Lefebvre | 40 | 221 | 5269 |
William B. Motherwell | 39 | 305 | 6357 |
Jean-Pierre Raynaud | 38 | 104 | 5075 |
André Lemay | 38 | 114 | 4264 |
Patrick J. Creaven | 32 | 102 | 3435 |